BE531163A - - Google Patents

Info

Publication number
BE531163A
BE531163A BE531163DA BE531163A BE 531163 A BE531163 A BE 531163A BE 531163D A BE531163D A BE 531163DA BE 531163 A BE531163 A BE 531163A
Authority
BE
Belgium
Prior art keywords
compound
anisyl
bis
hydrochloride
substituted
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE531163A publication Critical patent/BE531163A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE531163D BE531163A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE556720T

Publications (1)

Publication Number Publication Date
BE531163A true BE531163A (es)

Family

ID=3872575

Family Applications (2)

Application Number Title Priority Date Filing Date
BE531163D BE531163A (es)
BE556720D BE556720A (es)

Family Applications After (1)

Application Number Title Priority Date Filing Date
BE556720D BE556720A (es)

Country Status (1)

Country Link
BE (2) BE556720A (es)

Also Published As

Publication number Publication date
BE556720A (es)

Similar Documents

Publication Publication Date Title
EP0377528B1 (fr) Pipéridines, procédés de préparation et médicaments les contenant
CA1101872A (fr) Procede de preparation de nouveaux derives de la pyrrolidine
EP0063509A1 (fr) Nouveaux dérivés de pipérazino-2 pyrimidine, procédés pour leur préparation, médicaments les contenant et leur utilisation comme intermédiaires pour la fabrication de médicaments
EP0147312A2 (fr) Nouvelles imidazo /1,2-c/ pyrimidines et leurs sels, leur procédé de préparation, leur application à titre de médicaments et les compositions les renfermant
BE531163A (es)
CA1217489A (fr) Derives de la piperidine et leurs procedes de preparation
FR2547822A1 (fr) Acylpiperazinoquinazolines substituees utiles comme medicaments et procede pour leur preparation
EP0176444B1 (fr) Nouveau procédé de préparation de dérivés du 4 H-1,2-4-triazole, nouveaux triazoles ainsi obtenus, leur applicication comme médicaments et les compositions pharmaceutiques les renfermant
CA1098524A (fr) Procede de preparation de nouveaux derives de l'acide piperazinecarbodithioique
CA2018485A1 (fr) Derives de phenyl-1-dihydro-1,4 amino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique
EP0157762B1 (fr) Nouvelles piperidinoguanidines substituees, leur procede de preparation et les compositions pharmaceutiques en renfermant
EP0099822B1 (fr) Nouveaux 1-(2-carbalkoxy 4-(thiénylalkylamido)phénoxy) 3-amino 2-propanols, leur préparation et leurs applications en thérapeutique
FR2491471A1 (fr) Benzoxazolinones substituees, leur preparation et leur application en therapeutique
BE583205A (es)
FR2473512A1 (fr) Nouveaux 2-aminomethyl-6-halogeno-phenols, leur preparation et leur application comme medicaments
EP0007843A1 (fr) Dérivés de propiophénone, leur application en thérapeutique et leur préparation
EP0233804A1 (fr) Monoaryl-5 as triazinones-3 substituées en position 2, leur procédé de préparation et leur application en tant que medicaments
JPH0449550B2 (es)
BE493470A (es)
BE573096A (es)
BE477049A (es)
BE510679A (es)
FR2678266A1 (fr) Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
EP0950052A1 (fr) Procede pour la preparation d'un derive de tetrahydropyridine
BE528126A (es)